Showing results (71-80 of 98) with videos related to
Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|March 27, 2020
Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIVRyan P Coyle, Mary Morrow, Stacey S Coleman, et al.Journal of Clinical Pharmacology|December 17, 2011
Influence of SLCO1B1 polymorphisms on the drug-drug interaction between darunavir/ritonavir and pravastatinChristina L Aquilante, Jennifer J Kiser, Peter L Anderson, et al.The Journal of Antimicrobial Chemotherapy|May 14, 2019
Increased tenofovir monoester concentrations in patients receiving tenofovir disoproxil fumarate with ledipasvir/sofosbuvirKristina M Brooks, Jose R Castillo-Mancilla, Joshua Blum, et al.The Journal of Antimicrobial Chemotherapy|March 4, 2025
Cellular pharmacology of tenofovir alafenamide and emtricitabine in neutrophils and platelets in people with and without HIVVincent A Mainella, Brian Branchford, Travis Nemkov, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 2, 2020
Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes MellitusSarah C Mann, Mary Morrow, Ryan P Coyle, et al.AIDS and Behavior|February 25, 2019
Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral TherapyRyan P Coyle, Christopher D Schneck, Mary Morrow, et al.Open Forum Infectious Diseases|January 15, 2021
Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD StudyKristina M Brooks, Jose R Castillo-Mancilla, Mary Morrow, et al.Pharmacotherapy|February 17, 2021
Higher medication complexity in persons with HIV is associated with lower tenofovir diphosphate in dried blood spotsAustin M Saderup, Mary Morrow, Anne M Libby, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Sofosbuvir/Velpatasvir Concentrations in the Breastmilk of Postpartum Women with Opioid Use Disorder Receiving Treatment for Hepatitis C Virus: a pharmacokinetic studyCatherine A Chappell, Kristina M Brooks, Jennifer J Kiser, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-CSusanna Naggie, Kristen M Marks, Michael Hughes, et al.Pageof 10